Gayle Barbara Duncan
Affiliations
- Director at Ovid Therapeutics Inc. (OVID), 2024-02-26
- Director at Atea Pharmaceuticals Inc. (AVIR), 2023-06-21
- Director at Fusion Pharmaceuticals Inc. (FUSN), 2023-06-14
- at Halozyme Therapeutics Inc. (HALO), 2023-05-09
- Director at Jounce Therapeutics Inc. (JNCE), 2023-05-04
- Director at Adaptimmune Therapeutics Plc (ADAP), 2022-07-01
- Director at Immunomedics Inc (IMMU), 2020-10-23
- Director at Aevi Genomic Medicine Inc. (GNMX), 2020-02-05
- Director at Innoviva Inc. (INVA), 2017-04-24
- Chief Accounting Officer at Intercept Pharmaceuticals Inc (ICPT), 2016-10-06
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| GNMX | $1.26 | 59,524 | Director | 59,524 | 2017-10-17 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| JNCE | $10.50 | 5,000 | Director | 0 | 2020-09-15 | Filing | |
| JNCE | $9.50 | 5,000 | Director | 5,000 | 2020-09-15 | Filing | |
| JNCE | $28.11 | 2,000 | Director | 0 | 2018-03-15 | Filing | |
| JNCE | $25.00 | 4,000 | Director | 0 | 2018-01-26 | Filing | |
| ICPT | $163.20 | 147 | Officer | 30,661 | 2016-10-03 | Filing |